Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Products > Novel inhibitors

Novel inhibitors

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC1031 Bm-573
Dual thromboxane synthase inhibitor and thromboxane receptor antagonist
More description
DCC1030 Bm-520
Original TXA2 modulator, inhibiting the action of thromboxane A2 and 8-iso-prostaglandin F2alpha
More description
DCC1029 Azaguanine-8
Inhibitor of Marburg virus (MARV) growth at noncytotoxic concentrations
More description
DCC1028 Calpain Inhibitor Ii
Inhibitor of calpain, cathepsin L and cathepsin B
More description
DCC1027 Bl-ei001
Novel ERK inhibitor, inducing breast cancer cell apoptosis via mitochondrial pathway but independent on Ras/Raf/MEK pathway
More description
DCC1026 Blapsin B
Potent 14-3-3 inhibitor
More description
DCC1025 Blapsin A
Natural Potent 14-3-3 inhibitor
More description
DCC1024 Blancoxanthone
Natural anti-coronavirus agent
More description
DCC1023 Bkm-570
Bradykinin antagonist, causing impressive growth inhibition of lung and prostate tumors, displaying superior in vivo inhibitory effects than convential chemotherapeutic drugs
More description
DCC1022 Bkm1972
Novel inhibitor of the expression of anti-apoptotic protein survivin and membrane-bound efflux pump ATP binding cassette B 1 (ABCB1, p-glycoprotein), presumably via signal transducer and activator of transcription 3 (Stat3), inhibiting human prostate canc
More description
DCC1021 Bkm1740
Novel effective inhibitor of survivin expression at both the mRNA and protein levels in vitro, significantly reducing survivin in bone metastatic C4-2 tumors
More description
DCC1020 Bkm1644
Novel inhibitor of survivin transcription through a signal transducer and activator of transcription 3 (Stat3)-dependent mechanism, inhibiting tissue expression of survivin and inducing apoptosis in C4-2 skeletal tumor
More description
DCC1019 Bki-1814
Novel potent and selective bumped kinase inhibitor (BKI) CpCDPK1 IC 50 0.005 µM
More description
DCC1018 Bki-1812
Novel potent and selective bumped kinase inhibitor (BKI) CpCDPK1 IC 50 0.0025 µM
More description
DCC1017 Bki-1770
Novel Bumped-Kinase Inhibitor (BKI) for Cryptosporidiosis Therapy
More description
DCC1016 Bki-1708
Novel Bumped-Kinase Inhibitor (BKI) for Cryptosporidiosis Therapy
More description
DCC1015 Bjp-06-005-3
Novel potent and selective covalent Pin1 inhibitor
More description
DCC1014 Bjff078
Potent inhibitor of recombinant human and mouse Transglutaminase enzyme activity, mainly TG2 and the close related enzyme TG1
More description
DCC1013 Bix-02188me
Potent and selective dual inhibitor of MEK5 and ERK5
More description
DCC1012 Bit-l15
Novel potent antagonist of RORγt function, displaying an increased selectivity for RORγt over RORα and PPARγ compared to the purely orthosteric and allosteric non-PEG-linked parent compounds
More description
DCC1011 Bitc-sg
Inactivator of GSTP1>GST P1-1 through the covalent modification of two Cys47 residues per dimer and one Cys101
More description
DCC1010 Bisthianostat
Novel Orally Efficacious Pan-HDAC Inhibitor
More description
DCC1009 Bis-salicyl Fumarate
Potent activator of the Neh2-luc reporter
More description
DCC1008 Bisoctrizole
UV stabilizer
More description
DCC1007 bis-n-norgliovictin
Novel inhibitor of LPS-induced inflammation in macrophages, improving survival in sepsis
More description
DCC1006 Bisleuconothine A
Novel and selective Wnt signaling inhibitor
More description
DCC1005 Bisindole-pbd
Novel inhibitor of angiogenesis by regulating STAT3 and VEGF in breast cancer cells
More description
DCC1004 Bisdionin F
Selective hAMCase Inhibitor
More description
DCC1003 Bis-cyclosal-d4tmp
Novel anti-HIV active dimeric prodrug of 2‘,3‘-dideoxy-2‘,3‘-didehydrothymidine monophosphate (d4TMP)
More description
DCC1002 Bisaramil
Class I antiarrhythmic agent with chronotropic, inotropic, dromotropic and coronary vasodilator effects, potently blocking sodium channel
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X